Common Side Effects: Nausea and vomiting Diarrhea or constipation Fatigue Dizziness Gas Indigestion or heartburn Serious Side Effects: Increased heart rate Low blood sugar (Hypoglaecemia) Thyroid cancer (Wegovy comes with a boxed warning.) Kidney damage Side Effects for Specific Groups: Pregnant women: Wegovy should be avoided during pregnancy due to potential harm to the unborn fetus
Phase 3 trials showed weight loss of up to 11.2% at the highest dose over 72 weeks
Whilst preliminary research suggests allulose may modestly increase endogenous GLP-1 secretion, no clinical trials have demonstrated enhanced efficacy when combined with prescribed GLP-1 receptor agonists
Scheda SIM Dispositivi collegati alla rete tramite una scheda SIM funzionante in tutta Europa, nessuna scheda o dispositivo di archiviazione che abbia bisogno di download costante
Understanding Medical Necessity for FSA Approval FSA plans increasingly cover weight loss medications when documented medical necessity exists
GLP-1 receptor : Agonism at the GLP-1 receptor provides appetite suppression through central hypothalamic and brainstem signaling, delays gastric emptying, and enhances glucose-dependent insulin secretion